Geode Capital Management’s Galmed Pharmaceuticals GLMD Stock Holding History

Geode Capital Management’s Portfolio GLMD Stock Details GLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-19	Closed	-$11.6K	–	4770
2023 Q1	$11.6K	Hold	19	–	–	﹤0.01%	4760
2022 Q4	$13K	Hold	19	–	–	﹤0.01%	4818
2022 Q3	$8K	Hold	19	–	–	﹤0.01%	5001
2022 Q2	$18K	Hold	19	–	–	﹤0.01%	4935
2022 Q1	$43K	Hold	19	–	–	﹤0.01%	4832
2021 Q4	$49K	Hold	19	–	–	﹤0.01%	4860
2021 Q3	$75K	Buy	19 +5	+36%	+$21K	﹤0.01%	4722
2021 Q2	$60K	Hold	14	–	–	﹤0.01%	4636
2021 Q1	$68K	Hold	14	–	–	﹤0.01%	4364
2020 Q4	$62K	Hold	14	–	–	﹤0.01%	4129
2020 Q3	$70K	Hold	14	–	–	﹤0.01%	3966
2020 Q2	$95K	Hold	14	–	–	﹤0.01%	3869
2020 Q1	$69K	Hold	14	–	–	﹤0.01%	3857
2019 Q4	$115K	Hold	14	–	–	﹤0.01%	3955
2019 Q3	$95K	Hold	14	–	–	﹤0.01%	3954
2019 Q2	$146K	Buy	14 +2	+17%	+$20.6K	﹤0.01%	3860
2019 Q1	$142K	Buy	12 +4	+50%	+$46.5K	﹤0.01%	3823
2018 Q4	$80K	Hold	8	–	–	﹤0.01%	3905
2018 Q3	$159K	Hold	8	–	–	﹤0.01%	3816
2018 Q2	$139K	Buy	+8	New	+$92.7K	﹤0.01%	3805
2016 Q1	–	Sell	-20	Closed	-$223K	–	4104
2015 Q4	$223K	Buy	20 +1	+5%	+$12.8K	﹤0.01%	3643
2015 Q3	$202K	Hold	19	–	–	﹤0.01%	3680
2015 Q2	$273K	Hold	19	–	–	﹤0.01%	3471
2015 Q1	$255K	Buy	19 +5	+36%	+$60.1K	﹤0.01%	3485
2014 Q4	$115K	Hold	14	–	–	﹤0.01%	3753
2014 Q3	$170K	Buy	14 +3	+27%	+$32.8K	﹤0.01%	3624
2014 Q2	$156K	Buy	+11	New	+$135K	﹤0.01%	3588

Other funds holding GLMD

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TFGT

TS Financial Group (TSFG) Lake Forest, Illinois $794M AUM 24.65% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

BCM

Bourgeon Capital Management Darien, Connecticut $679M AUM 50.89% 1-Year Est. Return

Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

Geode Capital Management's GLMD Position: Q2 2023 in Review

Geode Capital Management sold out of Galmed Pharmaceuticals (GLMD) in Q2 2023, closing a stake of 19 shares — an estimated $11.6K sold.

Geode Capital Management first reported a position in GLMD in Q2 2014 and held it in 27 quarters. The position peaked at $273K in Q2 2015. 8 funds tracked by Wall St. Rank hold GLMD as of Q2 2023.

Geode Capital Management reported no remaining Galmed Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Geode Capital Management sold 19 Galmed Pharmaceuticals shares in Q2 2023, an estimated $11.6K.
Geode Capital Management first reported a position in Galmed Pharmaceuticals in Q2 2014 and held it in 27 quarters.
Geode Capital Management's Galmed Pharmaceuticals position peaked at $273K in Q2 2015.
8 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q2 2023.

Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.